Loading data
RNXTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.12 m USD | 43 k USD | — | — | — |
| Cost of revenue | 327 k USD | 0 USD | — | — | — |
| Gross profit | 796 k USD | 43 k USD | — | — | — |
| Research and development expense | 6.27 m USD | 6.03 m USD | 5.67 m USD | 4.3 m USD | 3.04 m USD |
| Selling, general and administrative expense | 7.04 m USD | 4.99 m USD | 5.73 m USD | — | — |
| Operating profit | -12.51 m USD | -10.97 m USD | -11.4 m USD | -9.95 m USD | -5.67 m USD |
| Profit before tax | -11.17 m USD | -8.75 m USD | — | — | — |
| Income tax expense | 2 k USD | — | — | — | — |
| Net income (reported basis) | -11.2 m USD | -8.81 m USD | -10.23 m USD | -9.89 m USD | -6.32 m USD |
| Basic earnings per share | -0.32 USD/share | -0.4 USD/share | -0.99 USD/share | -1.09 USD/share | -1.21 USD/share |
| Diluted earnings per share | -0.32 USD/share | -0.4 USD/share | -0.99 USD/share | -1.09 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.